drugset / Trial / NCT01514422

Minocycline for Bipolar Depression

NCT01514422

Phase 4 Completed 20 enrolled Icahn School of Medicine at Mount Sinai
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate minocycline as a potential treatment for bipolar depression when added to a mood-stabilizing medication. Minocycline is an antibiotic that is approved for the treatment of infections and acne. Participation in this research study is expected to last 8 weeks, and includes five outpatient visits.

Timeline

Start
2011-05
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg
Subject Minocycline Small molecule 300 mg

Indications